Page 4 - Adjuvant Development Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covaxin neutralises both Alpha, Delta variants of Covid effectively, research by top US health institute finds SECTIONS Covaxin neutralises both Alpha, Delta variants of Covid effectively, research by top US health institute findsET Online Last Updated: Jun 30, 2021, 11:01 AM IST Share Synopsis The vaccine has so far been given to around 25 million recipients in India and elsewhere. Interim results from Covaxin's Phase 3 trial have reportedly shown over "78% efficacy against symptomatic disease, 100% efficacy against severe infection and 70% efficacy against asymptomatic infection." India's C...

Bharat Biotech's Covaxin effective against Delta variant of coronavirus: Top US research institute Two studies suggest that Bharat Biotech's Covaxin is effective against both Alpha and Delta variants of coronavirus, said the US' National Institute of Health (NIH). advertisement UPDATED: June 30, 2021 16:10 IST Covaxin has been administered to roughly 25 million people till date in India and elsewhere. (Image: AFP) Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), effectively neutralises both Alpha and Delta variants of coronavirus, said ...